Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Buchsbaum

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Seminars in Radiation Oncology|March 23, 2000
Experimental radioimmunotherapyD J Buchsbaum
Cancer|December 24, 1997
Experimental tumor targeting with radiolabeled ligandsD J Buchsbaum
Cancer Research|December 1, 1995
Experimental approaches to increase radiolabeled antibody localization in tumorsD J Buchsbaum
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1972
Effect of rat tumor allografts on the blood level of passively transferred alloantibodiesD J Buchsbaum
Cancer|February 1, 1994
A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodiesS Ram, D J Buchsbaum
Cancer|February 1, 1994
Radioiodination of monoclonal antibodies D612 and 17-1A with 3-iodophenylisothiocyanate and their biodistribution in tumor-bearing nude miceS Ram, D J Buchsbaum
International Journal of Peptide and Protein Research|July 1, 1996
Synthesis of a new class of isothiocyanatopeptide bifunctional chelating agents for coupling to monoclonal antibodiesS Ram, D J Buchsbaum
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|November 1, 1992
Development of 3-iodophenylisothiocyanate for radioiodination of monoclonal antibodiesS Ram, D J Buchsbaum
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Gene therapy for the treatment of cancerD J Buchsbaum, D T Curiel
Cancer Research|December 1, 1995
Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer modelP L Roberson, D J Buchsbaum
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Seminars in Radiation Oncology|March 23, 2000
Experimental radioimmunotherapyD J Buchsbaum
Cancer|December 24, 1997
Experimental tumor targeting with radiolabeled ligandsD J Buchsbaum
Cancer Research|December 1, 1995
Experimental approaches to increase radiolabeled antibody localization in tumorsD J Buchsbaum
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1972
Effect of rat tumor allografts on the blood level of passively transferred alloantibodiesD J Buchsbaum
Cancer|February 1, 1994
A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodiesS Ram, D J Buchsbaum
Cancer|February 1, 1994
Radioiodination of monoclonal antibodies D612 and 17-1A with 3-iodophenylisothiocyanate and their biodistribution in tumor-bearing nude miceS Ram, D J Buchsbaum
International Journal of Peptide and Protein Research|July 1, 1996
Synthesis of a new class of isothiocyanatopeptide bifunctional chelating agents for coupling to monoclonal antibodiesS Ram, D J Buchsbaum
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|November 1, 1992
Development of 3-iodophenylisothiocyanate for radioiodination of monoclonal antibodiesS Ram, D J Buchsbaum
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Gene therapy for the treatment of cancerD J Buchsbaum, D T Curiel
Cancer Research|December 1, 1995
Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer modelP L Roberson, D J Buchsbaum
Pageof 10